Breaking News Instant updates and real-time market news.

LLNW

Limelight Networks

$4.48

0.12 (2.75%)

, URI

United Rentals

$144.32

0.98 (0.68%)

17:32
10/18/17
10/18
17:32
10/18/17
17:32

On The Fly: After Hours Movers

UP AFTER EARNINGS: Limelight Networks (LLNW), up 10%... United Rentals (URI), up 2.1%... Kinder Morgan (KMI), up 1.7%. ALSO HIGHER: Adobe Systems (ADBE), up 8.6% after it provided better than expected guidance for fiscal 2018 and reaffirmed its fourth quarter guidance... Conatus (CNAT), up 6.8% after its drug IDN-7314 received orphan drug designation from the EMA. DOWN AFTER EARNINGS: eBay (EBAY), down 5.6%... Hexcel (HXL), down 1.6%... Crown Castle (CCI), down 1%. ALSO LOWER: Earthstone Energy (ESTE), down 7% after it filed to sell 4.5M shares... Pattern Energy (PEGI), down 4.2% after it filed to sell 8M shares of Class A common stock... Ignyta (RXDX), down 3.4% after it announced a $125M common stock offering... HCA Healthcare (HCA), down 2.5% after it provided conservative guidance for the third quarter and lowered its guidance for fiscal 2017... KLA-Tencor (KLAC), down 1% after it was removed from the Focus List at Credit Suisse.

LLNW

Limelight Networks

$4.48

0.12 (2.75%)

URI

United Rentals

$144.32

0.98 (0.68%)

KMI

Kinder Morgan

$18.58

-0.1 (-0.54%)

ADBE

Adobe

$153.00

2.62 (1.74%)

CNAT

Conatus

$5.15

0.05 (0.98%)

EBAY

eBay

$37.97

0.48 (1.28%)

HXL

Hexcel

$58.94

0.39 (0.67%)

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

ESTE

Earthstone Energy

$10.54

-0.15 (-1.40%)

PEGI

Pattern Energy

$24.53

(0.00%)

RXDX

Ignyta

$16.25

1.9 (13.24%)

HCA

HCA Healthcare

$77.45

0.63 (0.82%)

KLAC

KLA-Tencor

$108.09

0.08 (0.07%)

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 26

    Oct

  • 06

    Nov

  • 06

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

LLNW Limelight Networks
$4.48

0.12 (2.75%)

04/05/17
COWN
04/05/17
NO CHANGE
Target $3
COWN
Outperform
Limelight Networks remains meaningfully undervalued, says Cowen
Cowen analyst Jonathan Charbonneau met with Limelight Networks management and reaffirmed the company is striking a nice balance between growth and margin expansion and he believes they are well positioned to take market share. He remains bullish on the name and said it is meaningfully undervalued. Charbonneau reiterated his Outperform rating and $3 price target on Limelight Networks shares.
10/16/17
DADA
10/16/17
NO CHANGE
Target $5.5
DADA
Buy
Limelight Networks to continue market share gains, says DA Davidson
DA Davidson analyst Mark Kelleher raised his price target on Limelight Networks (LLNW) to $5.50 from $4.50 and maintained his Buy rating ahead of the company's Q3 earnings. Kelleher notes that Limelight is laying a foundation for growth beyond 2017 with new customer wins in numerous vertical markets, and further improvements in its infrastructure will add an upward bias to gross margins next year and beyond. The analyst expects continued market share gains to outpace its largest competitor Akamai Technologies (AKAM), which he expects to show another decline in Media delivery business.
04/25/17
COWN
04/25/17
NO CHANGE
Target $4
COWN
Outperform
Limelight Networks remains undervalued as momentum continues, says Cowen
Cowen analyst Jonathan Charbonneau said momentum has continued for Limelight Networks and the shares remain undervalued. Charbonneau noted the company reported solid Q1 results and slightly increased full year guidance. Charbonneau reiterated his Outperform rating and raised his price target to $3.50 from $3.00 on Limelight Networks shares, as he thinks fundamentals, including robust traffic growth and stable pricing, should be sustainable beyond 2017.
10/27/16
COWN
10/27/16
NO CHANGE
Target $3
COWN
Outperform
Limelight Networks results suggest improving revenue trends, says Cowen
Cowen analyst Jonathan Charbonneau noted Limelight Networks reported muted Q3 results, but said recent momentum suggests improving revenue trends. The analyst believes the recent pickup in sales momentum and an increased focus on growth should lead to more consistent results going forward. Charbonneau believes Limelight Networks' current valuation meaningfully undervalues its fundamental business and reiterated his Outperform rating and $3 price target on the shares.
URI United Rentals
$144.32

0.98 (0.68%)

10/03/17
10/03/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Xerox (XRX) initiated with a Neutral at UBS. 2. United Rentals (URI) reinstated with a Hold at Deutsche Bank. 3. Home Depot (HD) initiated with a Buy at Gordon Haskett. 4. TD Ameritrade (AMTD) reinstated with a Neutral at Goldman Sachs. 5. West Pharmaceutical (WST) initiated with an Equal Weight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/17
JEFF
10/16/17
NO CHANGE
Target $165
JEFF
Buy
United Rentals price target raised to $165 from $150 at Jefferies
Jefferies analyst Justin Jordan raised his price target for United Rentals to $165 saying he expects a beat and raise quarter when the company reports on October 18. The Neff acquisition completion and an improving rental outlook should drive a 2017 guidance raise, Jordan tells investors in a pre-earnings research note. The analyst keeps a Buy rating on the shares.
09/05/17
JEFF
09/05/17
NO CHANGE
Target $150
JEFF
Buy
Hurricane Harvey to boost growth at United Rentals, says Jefferies
Jefferies analyst Justin Jordan believes United Rentals may see $60M of immediate disaster recovery revenue from Hurricane Harvey, which equates to 1% of sales and EBITDA in 2017. The estimate does not include rebuild rental work and the possibility of Harvey being a positive catalyst for increased U.S. infrastructure spending, Jordan tells investors in a research note. The analyst keeps a Buy rating on the shares.
10/03/17
DBAB
10/03/17
INITIATION
Target $157
DBAB
Hold
United Rentals reinstated with a Hold at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase reinstated United Rentals with a Hold rating and raised her price target for the shares to $157 from $130. The rating is unchanged. The new price target reflects the recently completed Neff acquisition, which the analyst views in a "favorable light financially."
KMI Kinder Morgan
$18.58

-0.1 (-0.54%)

10/17/17
GSCO
10/17/17
DOWNGRADE
Target $22
GSCO
Neutral
Kinder Morgan downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Theodore Durbin downgraded Kinder Morgan to Neutral citing a more balanced risk/reward profile following the realization of catalysts. The analyst also sees ongoing regulatory and execution risk. He cut his price target for the shares to $22 from $26.
07/27/17
07/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kinder Morgan (KMI) initiated with a Neutral at Mizuho. 2. Alpine Immune Sciences (ALPN) initiated with a Buy at Ladenburg. 3. Synaptics (SYNA) resumed with an Outperform at Cowen. 4. BioMarin (BMRN) and Ultragenyx (RARE) were initiated with a Market Perform at Bernstein. 5. Keane Group (FRAC) and ProPetro Holding (PUMP) were initiated with an Overweight at Capital One. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/27/17
MZHO
07/27/17
INITIATION
Target $22
MZHO
Neutral
Kinder Morgan initiated with a Neutral at Mizuho
Mizuho analyst Brian Zarahn initiated Kinder Morgan with a Neutral and a $22 price target.
08/30/17
MSCO
08/30/17
UPGRADE
MSCO
Overweight
Dominion Midstream, Hess Midstream Partners upgraded at Morgan Stanley
As previously reported, Morgan Stanley analyst Tom Abrams upgraded Dominion Midstream (DM) and Hess Midstream Partners (HESM), both to Overweight from Equal Weight, as he sees better value in the space after a few months of sector underperformance. He particularly likes equities expected to show higher growth in Distributable Cash Flow per unit, which includes Dominion Midstream and Hess Midstream Partners, he tells investors. Abrams also reiterated his Overweight ratings on Energy Transfer Equity (ETE), Kinder Morgan (KMI), Antero Midstream Partners (AM) and Phillips 66 Partners (PSXP), also citing their valuations relative to their cash flow.
ADBE Adobe
$153.00

2.62 (1.74%)

10/16/17
10/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Citi (C) downgraded to Sell from Hold at Societe Generale with analyst Andrew Lim citing the bank's third quarter earnings report. 2. Deckers Brands (DECK) downgraded to Negative from Neutral at Susquehanna with analyst Sam Poser saying he believes its struggles will continue regardless of whether Marcato adds some of its people to the company's board. 3. Adobe (ADBE) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi saying the valuation is "relatively full" with the shares up 50% year-to-date. 4. Ulta Beauty (ULTA) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Matthew Fassler saying recent data points, including a slowdown in Sephora U.S. sales and Bloomberg SpendTrend, suggest a more complicated path to recovery. 5. Bristol-Myers (BMY) downgraded to Hold from Buy at Jefferies with analyst Jeffrey Holford saying the shares, following the recent rally, have "significant downside risk" should lung cancer trial CheckMate-227 fail. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/17
RBCM
10/16/17
NO CHANGE
Target $157
RBCM
Outperform
Adobe analyst day justifies some near-term caution, says RBC Capital
RBC Capital Matthew Hedberg looks ahead at Adobe analyst day this week with some near-term caution, expecting FY18 guidance to come below consensus. Hedberg says investors may already anticipate conservative earnings forecasts, but also sees some short-term risks around revenue amid slower growth in Digital Marketing segment and limited scope for upside in Digital Media. In the longer term, Hedberg says Adobe has the potential to deliver 15-20% EPS growth and would treat any pullback as an opportunity, maintaining an Outperform rating and $157 price target on the stock.
10/16/17
DBAB
10/16/17
DOWNGRADE
Target $160
DBAB
Hold
Adobe downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Nandan Amladi downgraded Adobe Systems to Hold saying the valuation is "relatively full" with the shares up 50% year-to-date. The analyst notes he's received more cautious feedback from partners on lengthening sales cycles in digital marketing, Adobe's main growth driver. Amladi keeps a $160 price target for the shares.
09/20/17
FBCO
09/20/17
NO CHANGE
Target $170
FBCO
Outperform
Adobe price target raised to $170 from $160 at Credit Suisse
Credit Suisse analyst Michael Nemeroff raised his price target for Adobe to $170 from $160 following quarterly results. The analyst remains positive on Adobe's business overall, and argues that investor sentiment heading into its Q3 print was very high, possibly too strong, which could cause the shares to dip in the near-term, which he would see as a good buying opportunity. Nemeroff reiterates an Outperform rating on the shares.
CNAT Conatus
$5.15

0.05 (0.98%)

12/20/16
STFL
12/20/16
NO CHANGE
STFL
Conatus price target raised to $7 from $5 at Stifel
Stifel analyst Stephen Willey says that Novartis' (NVS) decision to collaborate with Conatus (CNAT) on its emricasan treatment marks a positive turning point for Conatus. Willey notes that the deal provides Conatus with funding and the opportunity to "pursue combination development with Novartis' FXR agonist LJN452," which he believes has synergies with emricasan. The analyst keeps a Buy rating on Conatus.
10/06/17
GHSC
10/06/17
INITIATION
Target $16
GHSC
Buy
Conatus initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated Conatus with a Buy and $16 price target.
12/20/16
RHCO
12/20/16
NO CHANGE
RHCO
Conatus price target raised to $26 from $17 at SunTrust
After Conatus (CNAT) announced a partnership deal with Novartis (NVS), SunTrust analyst John Boris says the deal is "transformational" for Conatus. The analyst thinks that the deal will be worth about $1B to Conatus. He believes that the deal makes strategic sense to Conatus because of the potential synergies in the mechanism of action between its NASH treatment and that of Novartis (NVS). Boris keeps a Buy rating on Conatus.
04/21/17
ROTH
04/21/17
NO CHANGE
Target $12
ROTH
Buy
Conatus price target raised to $12 from $4 at Roth Capital
Roth Capital analyst Sa'ar Yaniv raised his price target for Conatus (CNAT) to $12 from $4 following discussions with management, 2016 results, assessment of the competitive cirrhosis space, and clarity from the Novartis (NVS) deal. The analyst believes Conatus' shares are undervalued and reiterates a Buy rating on the stock.
EBAY eBay
$37.97

0.48 (1.28%)

10/16/17
BARD
10/16/17
NO CHANGE
Target $38
BARD
Outperform
eBay shows signs of improving growth ahead of holidays, says Baird
Baird analyst Colin Sebastian continues to view eBay positively as Q3 once again shows signs of improving growth ahead of the holiday season. He believes the next three months are important milestones in demonstrating the resiliency of its platform transformation. Sebastian reiterated his Outperform rating and $38 price target on eBay shares.
10/18/17
BMOC
10/18/17
NO CHANGE
Target $40
BMOC
Market Perform
eBay price target raised to $40 from $36 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on eBay to $40, saying the revenue in Promoted Listings business will rise about 190% in FY17. Salmon says the company's decision to discontinue third-party product listings ads across eBay will result in greater adoption of Promoted Listings, which he sees as a $1B opportunity. The analyst maintains a Market Perform rating on eBay, awaiting more signs of acceleration in gross merchandise volume.
09/26/17
WELS
09/26/17
INITIATION
Target $45
WELS
Outperform
eBay resumed with an Outperform at Wells Fargo
Wells Fargo analyst Ken Sena resumed coverage on eBay with an Outperform and $45 price target.
10/11/17
10/11/17
UPGRADE
Target $76

Overweight
PayPal upgraded to Overweight on revised view of eBay risk at Morgan Stanley
As previously reported, Morgan Stanley analyst James Faucette upgraded PayPal (PYPL) to Overweight from Equal Weight, calling it among the few large companies that can deliver high-teens revenue and 20% EPS growth. While he previously was on the sidelines due to risk from its contract renegotiation with eBay (EBAY), he now believes the market may be overly concerned with it as he thinks the most likely renewal structure will feature rebates from PayPal to eBay, he tells investors. Faucette raised his price target on PayPal shares to $76 from $62. He also raised his price target on eBay to $33 from $29, though he keeps an Underweight rating on its shares.
HXL Hexcel
$58.94

0.39 (0.67%)

10/13/17
DBAB
10/13/17
NO CHANGE
DBAB
Deutsche Bank likes three Defense names into Q3 results
Ahead of the Aerospace & Defense earnings season which begins on October 18, Deutsche Bank analyst Myles Walton says he likes Boeing (BA), Huntington Ingalls (HII) and Raytheon (RTN) into the reports. Helping support the quarter was continued strong air traffic demand, inflecting defense spending outlays, and the increasing geopolitical threat environment, Walton tells investors in a research previewing the earnings for the sector. The analyst increased some price targets in the space, including Huntington Ingalls to $260 from $240, Barnes Group (B) to $77 from $70, Hexcel (HXL) to $66 from $60 and Spirit AeroSystems (SPR) to $83 from $75.
04/21/17
COWN
04/21/17
NO CHANGE
Target $57
COWN
Outperform
Hexcel dip should be bought, says Cowen
Cowen analyst Gautam Khanna said he would be a buyer of the dip in Hexcel shares despite its Q1 setback. He believes the company will return to its upward grind given accelerating 2018 earnings, high short interest and the firm's scarcity. Khanna reiterated his Outperform rating and $57 price target on Hexcel shares.
09/28/17
LOOP
09/28/17
INITIATION
LOOP
Hold
Hexcel initiated with a Hold at Loop Capital
Loop Capital analyst Chris Kapsch initiated Hexcel with a Hold rating and $61 price target.
07/26/17
VERT
07/26/17
DOWNGRADE
VERT
Hold
Hexcel downgraded to Hold from Buy at Vertical Research
Vertical Research analyst Robert Stallard downgraded Hexcel to Hold with a $54 price target saying the Q2 report was modestly below consensus and Aerospace sales were lower than expected.
CCI Crown Castle
$100.96

-0.42 (-0.41%)

10/18/17
KEYB
10/18/17
NO CHANGE
KEYB
KeyBanc says Softbank JV won't compete with primary business of tower operators
KeyBanc said it does not view Softbank's (SFTBF) joint venture with Australia's Lendlease as competitive to the tower operators' primary business, noting that the venture is likely to focus on rooftop sites in urban markets, but tower businesses generate the vast majority of their revenue on sites located outside urban areas. Publicly traded tower companies include American Tower (AMT), Crown Castle (CCI) and SBA (SBAC).
10/18/17
WELS
10/18/17
NO CHANGE
WELS
Wells Fargo 'surprised' tower stocks didn't react to SoftBank news
After it was reported that SoftBank (SFTBF) and Australian real estate company Lendlease formed a joint venture to purchase 8,000 cell tower sites in the U.S., Wells Fargo analyst Jennifer Fritzsche said she was "surprised" that tower company stocks did not react to this news. She had already thought if a T-Mobile (TMUS) and Sprint (S) merger deal was followed by T-Mobile CTO Neville Ray talking about network savings that the tower stocks "could take a hit," and this news may have given him "a much bigger arrow" in that quiver, she tells investors. Publicly traded tower companies include American Tower (AMT), Crown Castle (CCI) and SBA (SBAC).
10/16/17
OPCO
10/16/17
DOWNGRADE
OPCO
Perform
Crown Castle downgraded to Perform from Outperform at Oppenheimer
10/16/17
10/16/17
DOWNGRADE

Perform
Crown Castle downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Timothy Horan downgraded Crown Castle (CCI) to Perform from Outperform saying that recent reports denote a T-Mobile (TMUS)/Sprint (S) merger is imminent, and as it represents 40% of revenues and will be aggressively slashing supplier spending, which will offset growth in 600 MHz, FirstNet, 5G. The analyst sees a 70% probability of the deal receiving approval with major concessions and likely also attacking the wireline market and better able to compete with Verizon (VZ)/AT&T (T) on coverage/capacity.
ESTE Earthstone Energy
$10.54

-0.15 (-1.40%)

08/01/17
IMPC
08/01/17
INITIATION
Target $13
IMPC
Outperform
Earthstone Energy initiated with an Outperform at Imperial Capital
Imperial Capital analyst Jason Wangler started Earthstone Energy with an Outperform rating and $13 price target.
01/17/17
IBER
01/17/17
INITIATION
Target $19
IBER
Outperform
Earthstone Energy initiated with an Outperform at Iberia
Iberia analyst Blaise Angelico initiated Earthstone Energy with an Outperform and a $19 price target.
06/21/17
GHSC
06/21/17
DOWNGRADE
Target $11
GHSC
Neutral
Earthstone Energy downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Mike Kelly downgraded Helmerich & Payne to Neutral from Buy and slashed its price target to $11 from $17 to reflect a new commodity price deck. Seaport Global's Energy team reduced its long-term oil forecast to $40/bbl from $50/bbl to reflect "relentless" US production growth. The firm sees the potential for the oil market to be "significantly over supplied in 2018 and cut its oil price forecast for first half 2017 to $45/bbl from $55/bbl and first half 2018 to $35/bbl from $55/bbl.
01/31/17
GHSC
01/31/17
UPGRADE
GHSC
Buy
Earthstone Energy upgraded to Buy from Accumulate at Seaport Global
Seaport Global upgraded Earthstone Energy to Buy with a $17 price target to reflect encouraging results from two step-out wells testing the outer limits of its Permian position.
PEGI Pattern Energy
$24.53

(0.00%)

03/14/17
GSCO
03/14/17
INITIATION
Target $21
GSCO
Neutral
Pattern Energy initiated with a Neutral at Goldman
Target $21.
03/23/17
MACQ
03/23/17
DOWNGRADE
Target $20
MACQ
Neutral
Pattern Energy downgraded to Neutral from Outperform at Macquarie
Macquarie analyst James Ward downgraded Pattern Energy to Neutral and maintained its $20 price target. The analyst said Pattern's payout ratio is already stretched and said any equity issuances finance projects will need to be immediately accretive, which will be challenging, and expects relative underperformance to continue.
03/15/17
03/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with an Underweight at Cantor. 2. Pattern Energy (PEGI) initiated with a Neutral at Goldman. 3. Windstream (WIN) reinstated with a Neutral at JPMorgan. 4. ClearOne (CLRO) resumed with a Buy at B. Riley. 5. REV Group (REVG) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/02/17
BMOC
03/02/17
NO CHANGE
BMOC
Pattern Energy weakness creates buying opportunity, says BMO Capital
After Pattern reported weaker than expected Q4 results, BMO Capital analyst BenPham thinks that the market may have reacted badly to the $10M initial investment that the company may have to make in development. However, he says that the 4% decline in the stock is overdone as he expects the company's free cash flow and development trends to improve. The analyst keeps a $26 price target and an Outperform rating on the stock.
RXDX Ignyta
$16.25

1.9 (13.24%)

10/18/17
LTCO
10/18/17
NO CHANGE
Target $31
LTCO
Buy
Ignyta price target raised to $31 from $20.25 at Ladenburg
08/17/17
JPMS
08/17/17
NO CHANGE
JPMS
JPMorgan lists top SMID Biotechnology picks following Q2 results
Analysts at JPMorgan continue think selectively remains important in the small-to-mid cap Biotechnology space. The analysts listed their favorite ideas in "five key buckets." Amicus (FOLD) is the top long-term pick, Ironwood (IRWD) is the top pick among relative underperformers, Otonomy (OTIC) is the top play for a clinical/binary event, Sarepta (SRPT) is the name to take advantage of the recent share weakness, and Ignyta (RXDX) is the "underfollowed/undervalued" favorite, according to JPMorgan's Biotech team.
10/12/17
JPMS
10/12/17
NO CHANGE
Target $20
JPMS
Overweight
Street still underappreciating Ignyta's entrectinib, says JPMorgan
After hosting a conference call with a key opinion leader and an investor lunch with management, JPMorgan analyst Anupam Rama continues to believe the ROS1 fusion-positive non-small cell lung cancer opportunity for Ignyta's entrectinib is being underappreciated by the Street. Entrectinib will emerge as the best-in-class ROS1 inhibitor for non-small cell lung cancer at next week's World Lung Conference, Rama tells investors in a researhc note. He raised his price target for Ignyta shares to $20 from $18 and keeps an Overweight rating on the name.
05/15/17
PIPR
05/15/17
NO CHANGE
PIPR
Overweight
Ignyta breakthrough designation 'levels the field' with Loxo, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer said one of the key investor concerns regarding Ignyta's (RXDX) entrectinib has been a lack of breakthrough designation in patients with NTRK fusions, which was read as perhaps suggesting an "inferior" profile to Loxo Oncology's (LOXO) larotrectrinib. News that the FDA granted entrectinib the designation "levels the playing field" and should help ease investor concerns, said Schimmer, who keeps an Overweight rating on Ignyta shares.
HCA HCA Healthcare
$77.45

0.63 (0.82%)

10/18/17
RAJA
10/18/17
DOWNGRADE
RAJA
Market Perform
HCA Healthcare downgraded to Market Perform from Outperform at Raymond James
10/18/17
10/18/17
DOWNGRADE

Market Perform
Follow-up: HCA Healthcare downgraded to Market Perform at Raymond James
Raymond James analyst John Ransom downgraded HCA Healthcare to Market Perform from Strong Buy and trimmed estimates. The analyst said shares have appreciated by approximately 10% from recent lows and look fairly valued and thinks the latest compromise ACA deal has already stalled in Congress, given the news today.
10/16/17
BMOC
10/16/17
INITIATION
Target $90
BMOC
Outperform
HCA Healthcare initiated with an Outperform at BMO Capital
BMO Capital analyst Matt Borsch initiated HCA Healthcare with an Outperform and $90 price target due to its stable growth profile and strong free cash flow provide the company financial flexibility to grow organically or by way of acquisitions, in current and new markets.
10/13/17
JEFF
10/13/17
NO CHANGE
Target $92
JEFF
Buy
HCA Healthcare price target lowered to $92 from $100 at Jefferies
Jefferies analyst Brian Tanquilut lowered his price target for HCA Healthcare to $92 after revising his estimates to account for several moving parts, including a retroactive reduction in Texas Medicaid Waiver funding and an "uncertain outlook" for healthcare utilization. His analysis, however, suggests HCA's 2018 EBITDA guidance should bracket consensus. Tanquilut calls hurricanes a Q3 "wildcard," believing weather reduced EBITDA in the quarter by greater than $100M. The analyst keeps a Buy rating on HCA shares.
KLAC KLA-Tencor
$108.09

0.08 (0.07%)

09/13/17
GSCO
09/13/17
DOWNGRADE
GSCO
Neutral
KLA-Tencor downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Toshiya Hari downgraded KLA-Tencor to Neutral.
10/18/17
FBCO
10/18/17
NO CHANGE
FBCO
KLA-Tencor removed from Focus List at Credit Suisse
08/07/17
STFL
08/07/17
UPGRADE
STFL
Buy
KLA-Tencor upgraded on valuation, memory exposure at Stifel
As noted earlier, Stifel upgraded KLA-Tencor to Buy from Hold. As reasons for the upgrade, analyst Patrick Ho cited valuation and what he sees as the company's higher than expected exposure to memory. Target to $106 from $103.
08/06/17
STFL
08/06/17
UPGRADE
STFL
Buy
KLA-Tencor upgraded to Buy from Hold at Stifel

TODAY'S FREE FLY STORIES

CEQP

Crestwood Equity

$37.55

0.05 (0.13%)

19:40
09/23/18
09/23
19:40
09/23/18
19:40
Downgrade
Crestwood Equity rating change  »

Crestwood Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$24.16

-0.14 (-0.58%)

, PAA

Plains All American

$24.84

-0.08 (-0.32%)

19:37
09/23/18
09/23
19:37
09/23/18
19:37
Upgrade
Plains GP Holdings, Plains All American rating change  »

Plains GP Holdings…

PAGP

Plains GP Holdings

$24.16

-0.14 (-0.58%)

PAA

Plains All American

$24.84

-0.08 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$24.84

-0.08 (-0.32%)

19:36
09/23/18
09/23
19:36
09/23/18
19:36
Upgrade
Plains All American rating change  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

19:30
09/23/18
09/23
19:30
09/23/18
19:30
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

TLRY

Tilray

$123.16

-53.365 (-30.23%)

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

INTC

Intel

$46.64

-0.56 (-1.19%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

BRK.B

Berkshire Hathaway

$220.57

-1.24 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 10

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 28

    Nov

  • 03

    Mar

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:08
09/23/18
09/23
19:08
09/23/18
19:08
Earnings
Regal Beloit confirms 2018 adjusted diluted EPS guidance of $5.70-$6.00 »

Regal sees 2018 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:04
09/23/18
09/23
19:04
09/23/18
19:04
Hot Stocks
Regal Beloit announces planned CEO retirement »

Regal Beloit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TRXC

TransEnterix

$6.43

-0.035 (-0.54%)

18:14
09/23/18
09/23
18:14
09/23/18
18:14
Hot Stocks
TransEnterix acquires assets, intellectual property from MST Medical Surgery »

TransEnterix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

17:24
09/23/18
09/23
17:24
09/23/18
17:24
Hot Stocks
Box Office Battle: 'The House With a Clock in Its Walls' opens to $26.9M in U.S. »

Comcast (CMCSA)…

T

AT&T

$33.88

0.44 (1.32%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$57.04

-2.065 (-3.49%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

LGF.A

Lionsgate

$22.38

-0.09 (-0.40%)

DIS

Disney

$110.72

-0.9 (-0.81%)

VIAB

Viacom

$32.36

0.52 (1.63%)

VIA

Viacom

$34.50

-0.5 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

DVMT

Dell Technologies

$96.27

0.27 (0.28%)

17:04
09/23/18
09/23
17:04
09/23/18
17:04
Periodicals
Dell to interview banks for IPO instead of acquisition, WSJ reports »

Dell Technologies is said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$75.11

-0.06 (-0.08%)

16:23
09/23/18
09/23
16:23
09/23/18
16:23
Periodicals
WPP preparing to merge Young & Rubicam, digital ad firm VML, WSJ reports »

WPP new CEO Mark Read is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

16:15
09/23/18
09/23
16:15
09/23/18
16:15
Hot Stocks
Abbott announces positive clinical study results from MitraClip trial »

Abbott announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

12:59
09/23/18
09/23
12:59
09/23/18
12:59
Periodicals
AstraZeneca CEO warns of medicine shortages following Brexit, Reuters reports »

Britain could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:54
09/23/18
09/23
12:54
09/23/18
12:54
Periodicals
Volkswagen's Porsche dropping diesel in EV push, Reuters says »

Volkswagen's Porsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

12:49
09/23/18
09/23
12:49
09/23/18
12:49
Periodicals
Apple planning for delays to Battersea HQ, Bloomberg reports »

Apple is making…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PYPL

PayPal

$90.76

0.17 (0.19%)

12:43
09/23/18
09/23
12:43
09/23/18
12:43
Periodicals
PayPal replaces executive in charge of Venmo, WSJ reports »

PayPal is replacing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

MDT

Medtronic

$97.85

0.38 (0.39%)

12:37
09/23/18
09/23
12:37
09/23/18
12:37
Hot Stocks
Medtronic presents IN.PACT global study three-year data »

Medtronic announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

12:29
09/23/18
09/23
12:29
09/23/18
12:29
Hot Stocks
Comcast prevails with highest offer price in auction for Sky »

Comcast (CMCSA) published…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$97.85

0.38 (0.39%)

12:26
09/23/18
09/23
12:26
09/23/18
12:26
Hot Stocks
Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES »

Investigators unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

12:20
09/23/18
09/23
12:20
09/23/18
12:20
Hot Stocks
Boston Scientific announced positive 12-month data from IMPERIAL trial »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

12:16
09/23/18
09/23
12:16
09/23/18
12:16
Hot Stocks
Nightstar reports proof of concept data from dose escalation in XIRIUS trial »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/23/18
09/23
04:55
09/23/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.